Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

An Outpatient Study of the Effectiveness and Safety of Depakote ER in the Treatment of Mania/Bipolar Disorder in Children and Adolescents

ClinicalTrials.gov ID: NCT00067262

Public ClinicalTrials.gov record NCT00067262. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 10:15 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Depakote ER for the Treatment of Bipolar Disorder in Children and Adolescents

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine the safety and effectiveness of Depakote ER (Divalproex Sodium Extended-Release Tablets) compared to placebo in the treatment of bipolar disorder, manic or mixed type in children and adolescents ages 10-17 years.

Study identification

NCT ID
NCT00067262
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Abbott
Industry
Enrollment
150 participants

Conditions and interventions

Eligibility (public fields only)

Age range
10 Years to 17 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 2003 (Type not available)
Primary completion
Not listed
Completion
Not listed
Last update posted
Aug 4, 2006

Started 2003

United States locations

U.S. sites
16
U.S. states
12
U.S. cities
16
Facility City State ZIP Site status
Stanford University Stanford California 94304 —
Childrens National Medical Center Washington D.C. District of Columbia 20010 —
Not listed Altamonte Springs Florida 32701 —
Professional Clinical Research, Inc. Miami Florida 33161 —
Segal Institute for Clinical Research North Miami Florida 33161 —
Mountain West Clinical Trials Boise Idaho 83704 —
Capstone Clinical Research Libertyville Illinois 60031 —
Cientifica Inc at Praire View, Inc. Newton Kansas 67114 —
Not listed Lexington Kentucky 40509 —
LSU - Health Science Center New Orleans Louisiana 70112 —
Brentwood Research Institute Shreveport Louisiana 71101 —
New Oakland Child/Adoles and Family Center Clinton Township Michigan — —
Mercy Health Research Chesterfield Missouri 63017 —
Cutting Edge Research Group Oklahoma City Oklahoma — —
University of Texas Medical Branch Galveston Texas 77705 —
University of Texas Medical Branch Houston Texas 77058 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00067262, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 4, 2006 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00067262 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →